LAUREN HINK: Open Payments
NPI 1902294812 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 30 payments from 7 companies in 2025. Trend: 2023 $51 · 2024 $288 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 22 | $606 |
| Incyte Corporation | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Acera Surgical, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Cagent Vascular INC | 1 | $19 |
| Exelixis Inc. | 1 | $16 |
Products named: INTERSTIM, ZYNYZ, Stivarga, Restrata Wound Matrix, FRUZAQLA, Serrantor, CABOMETYX.
Industry payments across OK — which companies pay providers there.
